IRADIMED CORP (IRMD) Stock Price, Quote, News and Overview
NASDAQ:IRMD - Nasdaq - US46266A1097 - Common Stock - Currency: USD
IRMD Quote, Performance and Key Statistics
NASDAQ:IRMD (4/21/2025, 12:13:31 PM)
50.74
-1.03 (-1.99%)
The current stock price of IRMD is 50.74 USD. In the past month the price decreased by -1.39%. In the past year, price increased by 26.27%.
IRMD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.09 | 224.57B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.69 | 167.25B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.33 | 138.59B | ||
| SYK | STRYKER CORP | 27.68 | 128.79B | ||
| MDT | MEDTRONIC PLC | 15.23 | 104.30B | ||
| BDX | BECTON DICKINSON AND CO | 14.03 | 56.04B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.47 | 40.77B | ||
| IDXX | IDEXX LABORATORIES INC | 36.23 | 33.03B | ||
| RMD | RESMED INC | 23.73 | 30.80B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.39 | 27.52B | ||
| DXCM | DEXCOM INC | 39.67 | 25.66B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 14.76 | 21.78B |
Related stock screener links
About IRMD
Company Profile
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 160 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
Company Info
IRADIMED CORP
1025 Willa Springs Dr.
Winter Springs FLORIDA 32708 US
CEO: Roger Susi
Employees: 160
Company Website: https://www.iradimed.com/
Investor Relations: https://www.iradimed.com/investors/events
Phone: 14076778022
IRADIMED CORP / IRMD FAQ
What is the stock price of IRADIMED CORP today?
The current stock price of IRMD is 50.74 USD. The price decreased by -1.99% in the last trading session.
What is the ticker symbol for IRADIMED CORP stock?
The exchange symbol of IRADIMED CORP is IRMD and it is listed on the Nasdaq exchange.
On which exchange is IRMD stock listed?
IRMD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for IRADIMED CORP stock?
8 analysts have analysed IRMD and the average price target is 72.42 USD. This implies a price increase of 42.73% is expected in the next year compared to the current price of 50.74. Check the IRADIMED CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is IRADIMED CORP worth?
IRADIMED CORP (IRMD) has a market capitalization of 645.41M USD. This makes IRMD a Small Cap stock.
How many employees does IRADIMED CORP have?
IRADIMED CORP (IRMD) currently has 160 employees.
What are the support and resistance levels for IRADIMED CORP (IRMD) stock?
IRADIMED CORP (IRMD) has a support level at 49.91 and a resistance level at 51.92. Check the full technical report for a detailed analysis of IRMD support and resistance levels.
Is IRADIMED CORP (IRMD) expected to grow?
The Revenue of IRADIMED CORP (IRMD) is expected to grow by 8.74% in the next year. Check the estimates tab for more information on the IRMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy IRADIMED CORP (IRMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IRMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IRMD, evaluating the profitability, health, valuation and growth aspects
- IRADIMED CORP (IRMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IRADIMED CORP (IRMD) Sales and EPS estimates to see what analysts future expectations are.
- IRADIMED CORP (IRMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IRADIMED CORP (IRMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- IRADIMED CORP (IRMD) Stock Chart to make your own analysis
- IRADIMED CORP (IRMD) Latest news and press-releases to stay up to date.
Does IRADIMED CORP (IRMD) stock pay dividends?
IRADIMED CORP (IRMD) has a dividend yield of 1.2%. The yearly dividend amount is currently 1.08. Check the full fundamental report for a detailed analysis of IRMD dividend history, reliability and sustainability.
When does IRADIMED CORP (IRMD) report earnings?
IRADIMED CORP (IRMD) will report earnings on 2025-05-01.
What is the Price/Earnings (PE) ratio of IRADIMED CORP (IRMD)?
The PE ratio for IRADIMED CORP (IRMD) is 30.75. This is based on the reported non-GAAP earnings per share of 1.65 and the current share price of 50.74 USD. Check the full fundamental report for a full analysis of the valuation metrics for IRMD.
What is the Short Interest ratio of IRADIMED CORP (IRMD) stock?
The outstanding short interest for IRADIMED CORP (IRMD) is 2.53% of its float. Check the ownership tab for more information on the IRMD short interest.
IRMD Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to IRMD. When comparing the yearly performance of all stocks, IRMD is one of the better performing stocks in the market, outperforming 83.08% of all stocks.
IRMD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to IRMD. Both the health and profitability get an excellent rating, making IRMD a very profitable company, without any liquidiy or solvency issues.
IRMD Financial Highlights
Over the last trailing twelve months IRMD reported a non-GAAP Earnings per Share(EPS) of 1.65. The EPS increased by 11.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 26.26% | ||
| ROA | 19.56% | ||
| ROE | 22.15% | ||
| Debt/Equity | 0 |
IRMD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to IRMD. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 8.18% and a revenue growth 8.74% for IRMD